By Donato Paolo Mancini

Roche Holding AG (ROG.EB) on Thursday raised its 2018 sales outlook after first-quarter sales increased.

The Basel-based company said its sales rose to 13.6 billion Swiss francs ($13.8 billion) from CHF12.9 billion, beating expectations. According to a FactSet consensus estimate, Roche was forecast to post sales for EUR13.35 billion.

Sales are expected to grow at a low single-digit rate in the full year, the company said. The pharmaceutical company had previously forecast that sales would be stable compared to 2017 or rise by a low single-digit percentage.

The company also said it expects to further increase its dividend in Swiss francs.

Write to Donato Paolo Mancini at donatopaolo.mancini@dowjones.com

(END) Dow Jones Newswires

April 26, 2018 01:34 ET (05:34 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Roche (QX) Charts.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Roche (QX) Charts.